Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29617599 | 1.00 | KDM4E (0.33) | KDM4EGPR3ALDH1A1TSHRHSD17B10 | |
| Water SCHEMBL28095816 | 0.98 | KDM4E (0.32) | KDM4EGPR3ALDH1A1TSHRHSD17B10 | |
| SCHEMBL976367 | 0.84 | KDM4E (0.40) | KDM4EGPR3ALDH1A1HSD17B10TDP1 | |
| SCHEMBL30343302 | 0.83 | KDM4E (0.39) | KDM4EGPR3TDP1 | |
| D-Glutamate SCHEMBL2036307 | 0.80 | MC4R (0.36) | KDM4EALDH1A1TSHRCYP1A2ACHE | |
| SCHEMBL28440790 | 0.77 | TDP1 (0.35) | KDM4EGPR3TDP1CYP2A6CYP1A2 | |
| SCHEMBL15994595 | 0.72 | TDP1 (0.39) | KDM4EGPR3ALDH1A1TSHRHSD17B10 | |
| SCHEMBL27575535 | 0.69 | HPRT1 (0.41) | KDM4EALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL1893653 | 0.68 | HSD17B10 (0.41) | KDM4EALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL23018970 | 0.68 | CYP2A6 (0.36) | ALDH1A1CYP2A6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024177860-A1 | IN CHEMICO TEST FOR TOXICITY | LEBRUN LABS LLC (US) | 2024-08-29 | — | — | WO | claimed |
| US-20240260865-A1 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2024-08-08 | — | — | US | claimed |
| US-11969246-B2 | Method of producing thin enzyme-based sensing layers on planar sensors | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-04-30 | — | — | US | claimed |
| US-11903708-B2 | Switchable low voltage electrochemical sensing for interfering species rejection | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-02-20 | — | — | US | claimed |
| CN-114426929-B | Yeast engineering bacteria for producing sanguinarine by fermentation and application thereof | 浙江大学 | 2024-02-02 | — | — | CN | claimed |
| US-20230363672-A1 | METHOD OF PRODUCING THIN ENZYME-BASED SENSING LAYERS ON PLANAR SENSORS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2023-11-16 | — | — | US | claimed |
| US-11690544-B2 | Method of producing thin enzyme-based sensing layers on planar sensors | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-07-04 | — | — | US | claimed |
| CN-115304611-B | Dihydrobenzophenanthridine alkaloid compound in radix zanthoxyli, and extraction method and application thereof | 广西师范大学 | 2023-06-02 | — | — | CN | claimed |
| CN-113816967-B | Method, composition and application of bio-orthogonal photocatalytic oxidative dehydrogenation activated antitumor compound | 华南理工大学 | 2023-04-21 | — | — | CN | claimed |
| CN-115304611-A | Two pairs of dihydrobenzophenanthridine alkaloid compounds in radix zanthoxyli and extraction method and application thereof | 广西师范大学 | 2022-11-08 | — | — | CN | claimed |
| CN-111171039-B | Oxidative dehydrogenation method of compound with cell nucleus targeting light activation imaging and cancer cell killing capacity and application | 华南理工大学 | 2022-10-25 | — | — | CN | claimed |
| US-20220218639-A1 | TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2022-07-14 | — | — | US | claimed |
| CN-114426929-A | Yeast engineering bacterium for producing sanguinarine through fermentation and application thereof | 浙江大学 | 2022-05-03 | — | — | CN | claimed |
| CN-113816967-A | Method for activating anti-tumor compound through biological orthogonal photocatalytic oxidative dehydrogenation, composition and application | 华南理工大学 | 2021-12-21 | — | — | CN | claimed |
| CN-110437243-B | Method for extracting and separating six dihydrobenzophenanthridine alkaloids from macleaya microcarpa | 湖南农业大学 | 2020-08-14 | — | — | CN | claimed |
| CN-111171039-A | Oxidative dehydrogenation method of compound with cell nucleus targeting light activation imaging and cancer cell killing capacity and application | 华南理工大学 | 2020-05-19 | — | — | CN | claimed |
| CN-110437243-A | A method of extracting six kinds of dihydrobenzo phenanthridine alkaloids of separation from macleaya microcarpa Fedde | UNIV HUNAN AGRICULTURAL | 2019-11-12 | — | — | CN | claimed |
| CN-110054612-A | A kind of electroluminescent organic material and its application characterized by dihydrobenzo phenanthridines and benzo-aza ring | 中节能万润股份有限公司 | 2019-07-26 | — | — | CN | claimed |
| CN-109468351-A | The method of efficient Enzyme catalyzed synthesis sanguinarine and Chelerythrine | 湖南美可达生物资源股份有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-109468350-A | The method for synthesizing sanguinarine and Chelerythrine as substrate using macleaya cordata blade stoste | 湖南美可达生物资源股份有限公司 | 2019-03-15 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220218639-A1 | TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS | PLAT, PLG, PLAUR | KDM4E 4129/4885GPR3 3230/4885ALDH1A1 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.